LOS ANGELES, Jan. 04, 2026 (GLOBE NEWSWIRE) — Happy New Year! As 2026 begins, Nework extends warm wishes to customers, educators, partners, and technology enthusiasts everywhere. We sincerely thank you for your support in 2025–a year full of innovation, awards, and meaningful connections with our users. 2025 Highlights and Achievements In 2025, Nework strengthened its […]
Nework Celebrates Award-Winning 2025 and Looks Ahead to Smarter, Mobile Collaboration in 2026 Wishing everyone a prosperous new year, while continuing to empower home, education, and business users with innovative technology GlobeNewswire January 04, 2026 LOS ANGELES, Jan. 04, 2026 (GLOBE NEWSWIRE) — Happy New Year! As 2026 begins, Nework extends warm wishes to customers,
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Freeport-McMoRan Inc. (NYSE:FCX) securities. If you suffered a loss on your Freeport-McMoRan Inc. investment and would like to explore a potential
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("LENZ" or the "Company") (NASDAQ:LENZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether LENZ and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. ("Aerovironment" or the "Company") (NASDAQ:AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aerovironment and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP is investigating claims on behalf of investors of� agilon health, Inc. ("agilon" or the "Company") (NYSE:AGL).��Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com�or 646-581-9980, ext.�7980. The investigation concerns whether agilon and certain of its officers and/or directors have engaged in
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ:MREO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Mereo and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE:ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ADC Therapeutics and certain of its officers
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Lakeland Industries, Inc. ("Lakeland" or the "Company") (NASDAQ:LAKE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lakeland and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Alibaba Group Holding Limited ("Alibaba" or the "Company") (NYSE:BABA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Alibaba and certain of its officers and/or